Shop
Checkout
CONFERENCES
REPORTS
MEDIA
PROFESSIONAL
EDUCATIONAL
CHI home
about
contact us
request information
Home
All Reports
How To Order
Affiliated Reports
About Us
Contact Us
2012 Reports
Therapies for Solid Tumors
September 2012
Table of Contents
|
Tables and Figures
Single User - $1,495.00
Single Site - $2,995.00
Multi Site - $7,950.00
Alzheimer's Disease
July 2012
Table of Contents
|
Tables and Figures
Single User - $595.00
The New Generation of Antibody Therapeutics
June 2012
Table of Contents
|
Tables and Figures
Single User - $2,495.00
Single Site - $3,995.00
Multi Site - $9,950.00
Fragment-Based Drug Discovery
April 2012
Table of Contents
|
Tables and Figures
Single User - $795.00
Back-Up Compound Strategies
April 2012
Table of Contents
|
Tables and Figures
|
Executive Summary
Single User - $2,495.00
Single Site - $3,995.00
Multi Site - $9,950.00
Cloud Computing Usage in Biotech & Pharma Market Study
March 2012
Single User - $495.00
Cancer Vaccines Market Study
February 2012
Single User - $495.00
Hematological Cancer Therapies: Pipelines, Markets, and Business Considerations
February 2012
Table of Contents
|
Tables and Figures
Single User - $2,495.00
Single Site - $3,995.00
Multi Site - $9,950.00
First
1
Last
Toll-Like Receptor (TLR) Agonists & Antagonists
December 2012
Single User - $910.00
Single Site - $1,820.00
Multi Site - $2,730.00
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies
December 2012
Single User - $1,354.60
Single Site - $2,709.20
Multi Site - $4,063.80
Competitor Analysis: EGF-R Antibodies-Biosimilars and Biosuperiors
December 2012
Single User - $261.72
Single Site - $523.44
Multi Site - $785.16
Competitor Analysis: Herpes Virus Vaccines and Therapeutics
December 2012
Single User - $393.39
Single Site - $768.78
Multi Site - $1,180.17
Advisory Committees and Speaker Bureaux - Ensuring Compliance
December 2012
Single User - $745.00
Single Site - $2,595.00
Multi Site - $5,195.00
KOL Insight: Hepatitis C: the race for the first interferon-free regimen
December 2012
Single User - $4,995.00
Single Site - $9,990.00
Multi Site - $14,985.00
Co-promotion and Co-marketing Partnering Terms and Agreements
December 2012
Single User - $2,695.00
Single Site - $8,095.00
Multi Site - $13,475.00
Therapy Trends: Hepatitis C-KOL Insight Module
November 2012
Single User - $4,995.00
Single Site - $9,990.00
Multi Site - $14,985.00
Drug Delivery Partnering Terms and Agreements
November 2012
Single User - $2,995.00
Single Site - $8,995.00
Multi Site - $14,975.00
Competitor Analysis: VEGF Antibodies - Bevacizumab and Ranibizumab Biosimilars and Biosuperiors
November 2012
Single User - $392.58
Single Site - $785.16
Multi Site - $1,177.74
First
1
2
3
4
5
6
7
8
9
10
Last
ALL REPORTS
ALL REPORTS
2013
2012
2011
2010
2009
2008
2007
2006
2005
SERIES
Biological Therapeutic Products
Biomarkers & Diagnostics
BioPharma Strategy
Emerging and International Markets and Outsourcing:
Market Outlook, Strategies, Licensing and Mergers and Acquisitions
MSL-KOL
Outsourcing
Pharmaceutical Marketing
Resource Guides
Bioprocess & Manufacturing
Chemistry
Clinical Trials & Translational Medicine
Drug & Device Safety
Drug Discovery & Development
Biosimilars & Generic Markets
Imaging
Drug Targets
Genomics
Healthcare
IT & Informatics
Technology & Tools for Life Science
Therapeutic Indications
Adrenal Diseases
Alzheimer’s Disease
Anti-Viral and Therapeutics
Autoimmune Diseases and Therapeutics
Blood Disorders and Diseases
Cancer Research and Therapeutics
Cardiovascular
CNS
Diabetes
Epidemiology
Liver Diseases
Neurological Diseases and Therapeutics
Pain Management
Respiratory Disease and Therapeutics
Vaccines
Women’s Health